News
New test could improve warfarin monitoring
SAN FRANCISCO—Monitoring warfarin using a modified prothrombin time (PT) test can improve anticoagulation stability and long-term clinical...
News
Drug reverses dabigatran’s effects in elderly/impaired
Credit: CDC SAN FRANCISCO—An investigational, humanized antibody fragment known as idarucizumab can reverse the anticoagulation effects of...
News
HIV doesn’t hinder lymphoma patients’ response to ASCT
a cultured lymphocyte Credit: CDC SAN FRANCISCO—Patients with HIV-related lymphoma (HRL) should not be excluded from clinical trials of...
News
Maintenance prolongs PFS, not OS, in relapsed CLL
Credit: Linda Bartlett SAN FRANCISCO—Maintenance therapy with the anti-CD20 monoclonal antibody ofatumumab improves progression-free survival (PFS...
News
Combo shows promise for rel/ref MM
Credit: Linda Bartlett SAN FRANCISCO—Combination therapy involving a novel monoclonal antibody (mAb) produces encouraging activity in relapsed or...
News
Extended anticoagulation offers transient benefit
SAN FRANCISCO—New research indicates that extending anticoagulant therapy to 2 years can reduce the risk of recurrent venous thromboembolism (VTE...
News
Drug combats complications of SCD
SAN FRANCISCO—Pharmaceutical-grade L-glutamine can reduce the risk of complications in patients with sickle cell disease (SCD), according to new...
News
Approach can cure even high-risk FL, study suggests
The study showed that many patients transplanted in complete remission (CR) did not relapse and could be considered cured. Patients transplanted...
News
CKT more important than del(17p) in CLL, group finds
The study showed that CKT, defined as 3 or more distinct chromosomal abnormalities, was independently associated with inferior event-free survival...
News
LMWH should replace warfarin, doc says
Results of the phase 3 CATCH trial showed that long-term treatment with the LMWH tinzaparin was associated with a 35% lower risk of recurrent...
News
Magnesium disappoints in sickle cell disease
sickle cell disease Credit: St.
News
PFS improvement will translate to OS, speaker says
The overall survival (OS) data for this study are not yet mature, but the significant improvement in PFS will likely translate to improved OS in a...
News
A new standard of care for relapsed MM?
In the phase 3 ASPIRE trial, patients who received combination carfilzomib, lenalidomide, and dexamethasone (KRd) had superior progression-free...
News
Strategy could reduce TRALI after platelet transfusion
Studying TRALI cases reported to the American Red Cross, the investigators found evidence to support the idea that testing female AP donors who...
News
TACO linked to amount and type of blood product transfused
The risk of TACO increased with advancing age and with increases in the number of units transfused. TACO rates also appeared to be related to the...